Articles tagged with: NVAX
Clinical Trial Results for H1N1 Vaccine Expected Soon (NASDAQ:NVAX)
On December 2, 2009 Novavax, Inc. (NASDAQ:NVAX) announced that it has received encouraging primary data from the first stage of the Phase 2 trial. The trial is being carried out on the company’s newly developed …
Like a Jewel of Gold in a Swine’s Snout (AZN, GSK, NVS, SNY, WMT, SVA, CVM, NVAX, RHHBY.PK)
In April 2009 the nation received scary news; a virus was sweeping through Mexico and South America, and had reached the Southwestern United States. That virus was Swine Flu or H1N1, an influenza virus affectionately …
